The Relationship Between Circulating Irisin and Oxidative Stress in Gastric and Colorectal Cancer Patients

Overview

Journal Asian Pac J Cancer Prev

Specialty Oncology

Date 2022 Aug 29

PMID 36037118

Authors

Ahmed Abd Tumer

Farah A Rashid

Affiliations

Soon will be listed here.

Abstract

Objective: Gastric and colorectal cancers are two obesity-related cancers. Irisin is a dipo-myokine with an important role in the body's energy homeostasis. Oxidative Stress has a crucial role in tumorigenesis. Therefore, this study aims to investigate the association of circulating irisin with oxidative stress in gastric and colorectal cancer patients.

Methods: A case-control study involving 62 gastric and colorectal cancers and 22 healthy individuals was carried out. Serum irisin and Total Antioxidant Capacity were measured by sandwich enzyme-linked immunosorbed assay (ELIZA) kits. Total Oxidative Stress (TOS) was measured using colorimetric methods and oxidative stress index (OSI) was also calculated.

Results: Serum irisin decreased significantly (p<0.0001) in gastric and colorectal cancer cases compared to healthy individuals. The TOS and OSI levels increased significantly (p<0.0001) in gastric and colorectal cancer cases compared to healthy individuals. No significant correlation was found in terms of irisin, TOS, TAC, and OSI in gastric and colorectal cancer cases and control groups.

Conclusion: Circulating irisin decreases and oxidative stress increases in gastric and colorectal cancers. There is no correlation between irisin and oxidative stress. The mechanism by which irisin is associated with oxidative stress is still not clear.

Citing Articles

Evaluate the Serum of Irisin, Omentin-1, and Oxidative Status in Males with Prostatic Cancer.

Musa Sultan M, Hussein Abdullah T, Abbas Abdullah M, Al-Darkazali W, Sattar Harbi N Rep Biochem Mol Biol. 2024; 13(1):23-30.

PMID: 39582829 PMC: 11580124. DOI: 10.61186/rbmb.13.1.23.

The Role of the Myokine Irisin in the Protection and Carcinogenesis of the Gastrointestinal Tract.

Pinkas M, Brzozowski T Antioxidants (Basel). 2024; 13(4).

PMID: 38671861 PMC: 11047509. DOI: 10.3390/antiox13040413.

Integrated oxidative stress score for predicting prognosis in stage III gastric cancer undergoing surgery.

Liu Y, Meng R, Zhu B, Zhan Q, Yang X, Ding G Pathol Oncol Res. 2023; 29:1610897.

PMID: 37334172 PMC: 10272382. DOI: 10.3389/pore.2023.1610897.

References

Eroglu M, Yilmaz N, Yalcinkaya S, Ay N, Aydin O, Sezer C . Enhanced HDL-cholesterol-associated anti-oxidant PON-1 activity in prostate cancer patients. Kaohsiung J Med Sci. 2013; 29(7):368-73. DOI: 10.1016/j.kjms.2012.11.004. View

Feng J, Lu L, Zeng P, Yang Y, Luo J, Yang Y . Serum total oxidant/antioxidant status and trace element levels in breast cancer patients. Int J Clin Oncol. 2011; 17(6):575-83. DOI: 10.1007/s10147-011-0327-y. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Williams P . Significantly greater reduction in breast cancer mortality from post-diagnosis running than walking. Int J Cancer. 2014; 135(5):1195-202. DOI: 10.1002/ijc.28740. View

Gannon N, Vaughan R, Garcia-Smith R, Bisoffi M, Trujillo K . Effects of the exercise-inducible myokine irisin on malignant and non-malignant breast epithelial cell behavior in vitro. Int J Cancer. 2014; 136(4):E197-202. DOI: 10.1002/ijc.29142. View

Erel O . A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005; 38(12):1103-11. DOI: 10.1016/j.clinbiochem.2005.08.008. View

Fournier A, Dos Santos G, Guillas G, Bertsch J, Duclos M, Boutron-Ruault M . Recent recreational physical activity and breast cancer risk in postmenopausal women in the E3N cohort. Cancer Epidemiol Biomarkers Prev. 2014; 23(9):1893-902. DOI: 10.1158/1055-9965.EPI-14-0150. View

Moon H, Mantzoros C . Regulation of cell proliferation and malignant potential by irisin in endometrial, colon, thyroid and esophageal cancer cell lines. Metabolism. 2013; 63(2):188-93. DOI: 10.1016/j.metabol.2013.10.005. View

Zhang Z, Zhang X, Li H, Liu T, Zhao Q, Huang L . Serum irisin associates with breast cancer to spinal metastasis. Medicine (Baltimore). 2018; 97(17):e0524. PMC: 5944558. DOI: 10.1097/MD.0000000000010524. View

10.

Kuloglu T, Celik O, Aydin S, Ozercan I, Acet M, Aydin Y . Irisin immunostaining characteristics of breast and ovarian cancer cells. Cell Mol Biol (Noisy-le-grand). 2016; 62(8):40-4. View

11.

Wu R, Feng J, Yang Y, Dai C, Lu A, Li J . Significance of Serum Total Oxidant/Antioxidant Status in Patients with Colorectal Cancer. PLoS One. 2017; 12(1):e0170003. PMC: 5245835. DOI: 10.1371/journal.pone.0170003. View

12.

Shahidi S, Hejazi J, Moghimi M, Borji S, Zabihian S, Fathi M . Circulating Irisin Levels and Redox Status Markers in Patients with Gastric Cancer: A Case-Control Study. Asian Pac J Cancer Prev. 2020; 21(10):2847-2851. PMC: 7798161. DOI: 10.31557/APJCP.2020.21.10.2847. View

13.

Gaggini M, Cabiati M, Del Turco S, Navarra T, De Simone P, Filipponi F . Increased FNDC5/Irisin expression in human hepatocellular carcinoma. Peptides. 2016; 88:62-66. DOI: 10.1016/j.peptides.2016.12.014. View

14.

Bostrom P, Wu J, Jedrychowski M, Korde A, Ye L, Lo J . A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012; 481(7382):463-8. PMC: 3522098. DOI: 10.1038/nature10777. View

15.

Xu Y, Rogers C . Physical Activity and Breast Cancer Prevention: Possible Role of Immune Mediators. Front Nutr. 2020; 7:557997. PMC: 7578403. DOI: 10.3389/fnut.2020.557997. View

16.

Bianchini F, Kaaks R, Vainio H . Overweight, obesity, and cancer risk. Lancet Oncol. 2002; 3(9):565-74. DOI: 10.1016/s1470-2045(02)00849-5. View

17.

Zhu H, Liu M, Zhang N, Pan H, Lin G, Li N . Serum and Adipose Tissue mRNA Levels of ATF3 and FNDC5/Irisin in Colorectal Cancer Patients With or Without Obesity. Front Physiol. 2018; 9:1125. PMC: 6140752. DOI: 10.3389/fphys.2018.01125. View

18.

Kubo A, Corley D . Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006; 15(5):872-8. DOI: 10.1158/1055-9965.EPI-05-0860. View

19.

Wang D, Feng J, Zeng P, Yang Y, Luo J, Yang Y . Total oxidant/antioxidant status in sera of patients with thyroid cancers. Endocr Relat Cancer. 2011; 18(6):773-82. PMC: 3230112. DOI: 10.1530/ERC-11-0230. View

20.

Holmes M, Chen W, Feskanich D, Kroenke C, Colditz G . Physical activity and survival after breast cancer diagnosis. JAMA. 2005; 293(20):2479-86. DOI: 10.1001/jama.293.20.2479. View